• National Cancer Institute
  • National Human Genome Research Institute

Adverse Outcomes in Clear Cell Renal Cell Carcinoma With Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2 - Ari Hakimi, TCGA Scientific Symposium 2012

You will need Adobe Flash Player 8 or later and JavaScript enabled to view this video.


Adverse Outcomes in Clear Cell Renal Cell Carcinoma With Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2 - Ari Hakimi, TCGA Scientific Symposium 2012




 >> View All Videos